Therapeutic N-heterocyclic carbenes: an interview with Alejandro Bugarin

Future Med Chem. 2022 Jul;14(13):941-942. doi: 10.4155/fmc-2022-0090. Epub 2022 May 25.

Abstract

Dr Bugarin is currently an Associate Professor of Chemistry and Physics at Florida Gulf Coast University. He has published more than 50 peer-reviewed publications (h-index = 18). His research group is developing new methodology to improve or reveal novel reactivity of triazenes, N-Heterocyclic carbenes, heterobimetallic catalysts, and other versatile molecules. In addition, he recently joined research efforts to build on the isolation, characterization, and biological evaluation of natural products.

Keywords: N-heterocyclic carbene; anticancer drug; antimicrobial drug; gold; interview; palladium; silver.

Publication types

  • Interview

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Biological Products*
  • Catalysis
  • Humans
  • Methane / analogs & derivatives
  • Methane / chemistry

Substances

  • Antineoplastic Agents
  • Biological Products
  • carbene
  • Methane